ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The translated BCR-ABL oncoprotein exhibits constitutive tyrosine kinase activity, which activates multiple signaling cascades involved in cell proliferation, survival, and genomic instability, driving the leukemogenic process in CML (Figure 1) [3,4].